Metropolis Healthcare Limited Stock

Equities

METROPOLIS

INE112L01020

Healthcare Facilities & Services

End-of-day quote NSE India S.E. 06:00:00 2024-07-17 pm EDT 5-day change 1st Jan Change
2,031 INR -0.46% Intraday chart for Metropolis Healthcare Limited -1.32% +21.03%
Sales 2024 12.08B 144M Sales 2025 * 13.54B 162M Capitalization 104B 1.24B
Net income 2024 1.28B 15.29M Net income 2025 * 1.77B 21.14M EV / Sales 2024 7.25 x
Net cash position 2024 712M 8.52M Net cash position 2025 * 2.37B 28.34M EV / Sales 2025 * 7.51 x
P/E ratio 2024
69.3 x
P/E ratio 2025 *
58.3 x
Employees 4,300
Yield 2024 *
0.48%
Yield 2025 *
0.53%
Free-Float 50.33%
More Fundamentals * Estimated data
Dynamic Chart
1 day-0.46%
1 week-1.32%
Current month+2.68%
1 month+3.88%
3 months+16.74%
6 months+29.78%
Current year+21.03%
More quotes
1 week
2 010.00
Extreme 2010
2 117.50
1 month
1 911.55
Extreme 1911.55
2 117.50
Current year
1 450.00
Extreme 1450
2 117.50
1 year
1 296.00
Extreme 1296
2 117.50
3 years
1 171.35
Extreme 1171.35
3 579.90
5 years
995.00
Extreme 995
3 579.90
10 years
907.00
Extreme 907
3 579.90
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-01-01
Director of Finance/CFO - 19-11-10
President - 87-06-30
Members of the board TitleAgeSince
Director/Board Member 69 20-05-13
Chairman 44 07-12-31
Director/Board Member 58 17-12-31
More insiders
Date Price Change Volume
24-07-18 2,031 -0.46% 80,859
24-07-16 2,040 -1.61% 90,855
24-07-15 2,074 +0.98% 402,542
24-07-12 2,054 -0.23% 150,686
24-07-11 2,058 +0.23% 158,895

End-of-day quote NSE India S.E., July 17, 2024

More quotes
Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services. The Company operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa, and the Middle East. The Company has spread its footprint across 20 Indian states and over 220 cities.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
2,031 INR
Average target price
1,933 INR
Spread / Average Target
-4.84%
Consensus
  1. Stock Market
  2. Equities
  3. METROPOLIS Stock